As NAD+ IV infusions gain popularity in functional and integrative medicine, it's crucial to understand who should avoid NAD+ therapy and why
Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]
These authors used antibody labelling of islets isolated from hIAPP transgenic mice to confirm the hypothesis that toxic IAPP oligomers form at all steps of the secretory pathway
To put that in perspective, every 5 mmHg reduction in systolic blood pressure lowers the risk of cardiovascular events by about 10 percent
Asia Pacific Journal of Clinical Nutrition, 17 Suppl 1, 167168
The incidence is estimated to be between 300,000 and 400,000 neonates globally each year, the majority in sub-Saharan Africa